[{"indications": "Indications\u00a0see notes above", "name": "ANTI-D (Rh0) IMMUNOGLOBULIN", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "14 Immunological products and vaccines", "14.5 Immunoglobulins", "14.5.3 Anti-D (Rh0) immunoglobulin", "ANTI-D (Rh0) IMMUNOGLOBULIN"], "cautions": "Cautions\u00a0immunoglobulin A deficiency; possible interference with live virus vaccines, see under %s\n(From 14.5.1 Normal immunoglobulin: British National Formulary)\nNormal immunoglobulin may interfere with the immune response to live virus vaccines which should therefore only be given at least 3 weeks before or 3 months after an injection of normal immunoglobulin (this does not apply to yellow fever vaccine since normal immunoglobulin does not contain antibody to this virus)., section 14.5.1,\r\nbut \n(From 14.5.3 Anti-D (Rh0) immunoglobulin: British National Formulary)\nNoteMMR vaccine may be given in the postpartum period with anti-D (Rh0) immunoglobulin injection provided that separate syringes are used and the products are administered into different limbs. If blood is transfused, the antibody response to the vaccine may be inhibited\u2014measure rubella antibodies after 6\u20138 weeks and revaccinate if necessary. about\r\nadministration with MMR vaccine", "side-effects": "Side-effects\u00a0nausea, vomiting, diarrhoea, abdominal pain; hypotension,\r\nhypertension, headache, fever, malaise, asthenia, drowsiness, dizziness,\r\nback pain, arthralgia, myalgia; pruritus, rash, sweating, injection\r\nsite pain; rarely tachycardia, anaphylaxis, dyspnoea,\r\nhypotension, and urticaria; (for side-effects associated with intravenous immunoglobulins, see section 14.5.1", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/106248.htm", "doses": ["See preparations below", "by intramuscular or intravenous injection, to rhesus-negative woman for prevention\r\nof Rh0(D) sensitisation:"]}]